Wound care costs the Canadian healthcare system $ 3.9 billion yearly1 and bacterially infected wounds cost 70 percent more to treat2. The presence of an increased bacterial load slows the healing of wounds3. With a portable point-of-care device like the MolecuLight I:X. provides valuable information in real time to inform and support the clinician’s decision making.
Working with the Sunnybrook Health Sciences Centre’s Complex Wound Service, 26 acute and chronic wounds were monitored to understand the benefits and potential of the MolecuLight device to improve wound care in multiple locations.
The project reports the following results with MolecuLight I:X.::
- 70% more evidence of increased bacterial load in wounds compared to the standard of care,
- 36% of clinical decisions were changed based on MolecuLight i: X. Images,
- Improved efficiency and coordination of care between multidisciplinary wound care teams at two hospital locations.
This made-inCanada Joint project between Sunnybrook and MolecuLight was activated by the CAN health network (Coordinated Accessible National), a federally funded program focused on growing Canadian solutions and helping businesses scale in the Canadian market while strengthening the healthcare system. The CAN Health Network is a national partnership made up of leading Canadian health organizations, known as Edges, and companies from across Canada Canada. The network is working together to bring new solutions to the healthcare system and pave the way for Canadian businesses not just to scale across the enterprise Canada, but global.
“Devices like MolecuLight are important tools that clinicians can use to provide additional information about their clinical judgment and make decisions,” he says Tracy DasGupta, Director, Interprofessional Practice, Sunnybrook Health Sciences Center. “In a multi-site environment, tools that provide just-in-time information can help expand our expertise to all care settings and assist clinicians with their evaluations and recommendations for care.”
“CAN Health has been most helpful in introducing our novel Canadian technology to wound care facilities such as Sunnybrook“says Anil Amlani, CEO of MolecuLight. “”Sunnybrooks Positive results reflect the clinical benefits that wound care centers around the world are experiencing and further suggest that I:X’s Useful in enabling improved clinical outcomes by informing physicians of the presence of increased bacterial load in wounds. “
“This unique device is exactly the kind of innovative Canadian technology that the CAN Health Network is helping to bring to the healthcare system,” he says DR. Dante Morra, Chairman of the CAN Health Network. “Through projects like this, health operators can get over Canada will have access to a made in Canada, proven solutions that have been tested by a trusted partner in the network. “
“As we recover from the COVID-19 pandemic, our government’s investment in the CAN Health Network is critical to helping our innovative healthcare companies grow and create jobs across the country,” said the Honorable Mary Ng, Minister for Small Business, Export Promotion and International Trade. “Partnerships like this one from the CAN Health Network support our health systems and health science innovators in bringing their made-in products to the tableCanada Health solutions for Canadians. “
1 CIHI. National Trends in Healthcare Spending, 1975 to 2011 (2011)
2 Nussbaum, SR et al. Cure worth. J. Int. Soc. Pharmacoeconomic results Res. 21, 27–32 (2018)
3Xu L. et al. The bacterial load predicts the rate of healing in diabetic neuropathic foot ulcers. 30 (2), 378- 80 (2007)
About MolecuLight Inc.
MolecuLight Inc. is a privately held medical imaging company that develops and commercializes its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s first commercially released device, the MolecuLight I:X. The fluorescence imaging system and accessories provide a handheld point-of-care imaging device for the global wound care market in the United States Detection of wounds with increased bacterial exposure (when used with clinical signs and symptoms) and for digital wound measurement. The company is commercializing its unique fluorescence imaging platform technology to other markets with globally relevant unmet needs, including food safety, consumer cosmetics, and other major industrial markets.
Via CAN Health Network
The CAN Health Network is a Canada-First approach to the introduction of technologies. It helps remove barriers to scale in healthcare and provides an environment for businesses to achieve their full potential. Currently in operation Ontario, Western and Atlantic CanadaThe CAN Health Network is planning an expansion Quebec and the north. The network received $ 6.75 million of the Federal Office for Economic Development for Southern Ontario (FedDev Ontario), $ 3.5 million of Western Economic Diversification Canada (WD), and last $ 2.2 million from the Atlantic Canada Opportunities Agency Establishment of a national platform that uses the purchasing power of health organizations. To learn more about the CAN Health Network, visit www.canhealthnetwork.ca.
Via FedDev Ontario
For almost 12 years FedDev Ontario has actively worked to advance and diversify the south Ontario Economy through funding opportunities and business services that support innovation and growth in Canada most populous region. The agency delivered impressive resultsthat can be seen in the south Ontario Companies that develop innovative technologies, improve their productivity, increase their revenues and promote the economic progress of communities in the region.
Enclosed and download at https://moleculight.box.com/s/4lwm57e9r9bhesqi87gwa1v2paecmb5o